Research Article
New-Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy in Renal Transplant Recipients
Table 2
The clinical and biochemical parameters of patients according to LVMI groups.
| | LVMI > 130 g/m2 (: 57) | LVMI ≤ 130 g/m2 (: 102) | value |
| Age (years) | 42.2 ± 10.6 | 37.2 ± 10.5 | 0.002 | Gender (M) | 44 (66.7%) | 74 (64.9%) | 0.871 | Dialysis duration (months) | 47.0 ± 49.5 | 35.8 ± 46.3 | 0.165 | Posttransplant duration (months) | 54.6 ± 52.2 | 55.4 ± 53.7 | 0.930 | GFR (mL/min) | 63.23 ± 23.87 | 72.65 ± 24.01 | 0.012 | Creatinine (mg/dL) | 1.4 ± 0.5 | 1.2 ± 0.5 | 0.049 | Albumin (g/L) | 4.0 ± 0.4 | 4.1 ± 0.3 | 0.43 | Hemoglobin (g/dL) | 13.2 ± 2.0 | 13.2 ± 1.9 | 0.845 | T. Chol (mg/dL) | 213.9 ± 52.4 | 209.7 ± 54.1 | 0.610 | LDL Chol (mg/dL) | 120.0 ± 40.0 | 117.9 ± 34.3 | 0.723 | HDL Chol (mg/dL) | 47.6 ± 14.2 | 49.2 ± 14.0 | 0.462 | Triglyceride (mg/dL) | 193.9 ± 88.2 | 164.4 ± 105.3 | 0.047 | Calcium (mg/dL) | 9.4 ± 0.6 | 9.2 ± 0.6 | 0.065 | Phosphorus (mg/dL) | 3.1 ± 0.5 | 3.2 ± 0.7 | 0.301 | PTH (pcg/mL) | 170.8 ± 115.1 | 157.2 ± 131.5 | 0.492 | Glucose (mg/dL) | 119.1 ± 52.2 | 93.8 ± 22.0 | 0.0001 | Office SBP (mmHg) | 143.9 ± 17.1 | 130.7 ± 21.9 | 0.0001 | Office DBP (mmHg) | 87.9 ± 10.4 | 82.3 ± 14.7 | 0.01 | HbA1c | 7.4 ± 1.6 | 6.3 ± 1.2 | 0.0001 | BMI (kg/m2) | 26.9 ± 4.4 | 25.3 ± 4.9 | 0.102 | Fat mass (kg) | 17.7 ± 8.1 | 16.2 ± 9.0 | 0.310 | Fat free mass (kg) | 55.8 ± 12.3 | 54.5 ± 9.4 | 0.532 | Visceral fat mass (kg) | 7.25 ± 3.8 | 6.42 ± 4.43 | 0.237 | Muscle mass (kg) | 53.7 ± 9.9 | 51.8 ± 9.0 | 0.244 |
|
|